19 Aug
AA amyloidosis is a systemic disease caused by persistent inflammation and prolonged serum amyloid A production. It most often affects the kidneys, leading to proteinuria, nephrotic syndrome, and progressive kidney dysfunction. This article explains the causes, clinical features, diagnosis, amyloid typing, and treatment of AA amyloidosis.
READ MORE16 Aug
AL amyloidosis is caused by abnormal immunoglobulin light chains produced by a clonal plasma-cell disorder. Learn about key symptoms, cardiac and renal red flags, diagnostic testing, biopsy, amyloid typing and treatment.
READ MORE14 Aug
ATTR amyloidosis is caused by the accumulation of misfolded transthyretin protein in tissues. Learn the differences between wild-type and hereditary ATTR, important cardiac and neurological red flags, how ATTR is diagnosed, the role of genetic testing, and current treatment approaches.
READ MORE14 Aug
ATTR and AL amyloidosis can both affect the heart but arise from different precursor proteins and require different treatment. Learn the key differences in causes, red flags, diagnosis, testing and management.
READ MORE14 Aug
Amyloidosis is a group of diseases caused by abnormal amyloid protein deposits in tissues and organs. Learn about AL, ATTR and AA amyloidosis, their symptoms, diagnosis and treatment.
READ MORE
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.